The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification.
Where this comes from
- Record sourced from PubMed, PMID 12707143.
- Also identified by DOI 10.1213/01.ANE.0000060451.82578.3A.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clonidine, an alpha(2)-adrenergic agonist, is used to minimize withdrawal symptoms related to ultra-rapid opioid detoxification procedures. These preliminary data suggest that clonidine possesses dose-related antidiarrheal activity.
Medical subject headings
- Adrenergic alpha-Agonists
- Clonidine
- Gastrointestinal Diseases
- Narcotics
- Substance Withdrawal Syndrome